State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Department of Pediatric Emergency, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
J Med Virol. 2023 Jan;95(1):e28371. doi: 10.1002/jmv.28371.
Autophagy is emerging as a critical player in host defense against diverse infections, in addition to its conserved function to maintain cellular homeostasis. Strikingly, some pathogens have evolved strategies to evade, subvert or exploit different steps of the autophagy pathway for their lifecycles. Here, we present a new viral mechanism of manipulating autophagy for its own benefit with severe fever with thrombocytopenia syndrome bunyavirus (SFTSV, an emerging high-pathogenic virus) as a model. SFTSV infection triggers autophagy, leading to complete autophagic flux. Mechanistically, we show that the nonstructural protein of SFTSV (NSs) interacts with mTOR, the pivotal regulator of autophagy, by targeting its kinase domain and captures mTOR into viral inclusion bodies (IBs) induced by NSs itself. Furthermore, NSsimpairs mTOR-mediated phosphorylation of unc-51-like kinase 1 (ULK1) at Ser757, disrupting the inhibitory effect of mTOR on ULK1 activity and thus contributing to autophagy induction. Pharmacologic treatment and Beclin-1 knockout experimental results establish that, in turn, autophagy enhances SFTSV infection and propagation. Moreover, the minigenome reporter system reveals that SFTSV ribonucleoprotein (the transcription and replication machinery) activity can be bolstered by autophagy. Additionally, we found that the NSs proteins of SFTSV-related bunyaviruses have a conserved function of targeting mTOR. Taken together, we unravel a viral strategy of inducing pro-viral autophagy by interacting with mTOR, sequestering mTOR into IBs and hence provoking the downstream ULK1 pathway, which presents a new paradigm for viral manipulation of autophagy and may help inform future development of specific antiviral therapies against SFTSV and related pathogens.
自噬在宿主防御多种感染中起着关键作用,除了其维持细胞内稳态的保守功能。引人注目的是,一些病原体已经进化出逃避、颠覆或利用自噬途径不同步骤的策略,以维持其生命周期。在这里,我们提出了一种新的病毒机制,即操纵自噬为自身利益服务,以严重发热伴血小板减少综合征 bunyavirus (SFTSV,一种新兴的高致病性病毒) 作为模型。SFTSV 感染触发自噬,导致完全自噬通量。从机制上讲,我们表明 SFTSV 的非结构蛋白 (NSs) 通过靶向其激酶结构域与自噬的关键调节因子 mTOR 相互作用,并将 mTOR 捕获到 NSs 自身诱导的病毒包含体 (IB) 中。此外,NSs 会破坏 mTOR 介导的 unc-51 样激酶 1 (ULK1) 在 Ser757 上的磷酸化,破坏 mTOR 对 ULK1 活性的抑制作用,从而促进自噬的诱导。药理学治疗和 Beclin-1 敲除实验结果证实,反过来,自噬增强了 SFTSV 的感染和复制。此外,迷你基因组报告系统显示,自噬可以增强 SFTSV 核糖核蛋白 (转录和复制机制) 的活性。此外,我们发现 SFTSV 相关 bunyavirus 的 NSs 蛋白具有与 mTOR 相互作用、将 mTOR 隔离到 IBs 中并进而引发下游 ULK1 途径的保守功能,这为病毒诱导促病毒自噬提供了一个新的范例,可能有助于为 SFTSV 和相关病原体的特定抗病毒治疗提供信息。